Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1186/s12890-021-01453-2 http://scihub22266oqcxt.onion/10.1186/s12890-021-01453-2 33761886!7988245!33761886     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=33761886&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215       BMC+Pulm+Med 2021 ; 21 (1): 102 Nephropedia Template TP {{tp|p=33761886|t=2021. An unexpected case of recurrence of pulmonary embolism in a patient recovered from COVID19 in full regimen dose of direct oral anticoagulant drug |pdf=|usr=}}{{33761886}} gab.com Text An unexpected case of recurrence of pulmonary embolism in a patient recovered from COVID19 in full regimen dose of direct oral anticoagulant drug JO: BMC Pulm Med http://www.kidney.de/pget.php?&tw=1&pmid=33761886 #FOAvip BACKGROUND: Coronavirus Disease 2019 (COVID-19) is a pandemic affecting all countries in the world. Italy has been particularly afflicted by the health emergency, and since the peak phase has passed, major concern regarding medium to long term complications due to COVID-19 is arising. Little is known in literature regarding thromboembolic complications once healed after COVID-19. CASE PRESENTATION: A 51-year-old patient recovered from COVID-19 pneumonia complicated by pulmonary embolism (PE) came to the hospital for palpitations and chest pain. Although he was on treatment dose of direct oral anticoagulation (DOAC), massive recurrent PE was diagnosed. CONCLUSION: In the early post COVID-19 era, the question remains regarding the efficacy of DOACs in COVID-19 patients. Twit Text FOAVip An unexpected case of recurrence of pulmonary embolism in a patient recovered from COVID19 in full regimen dose of direct oral anticoagulant drug ????BMC Pulm Med http://www.kidney.de/pget.php?&tw=1&pmid=33761886 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33761886 #FOAvip English Wikipedia <ref>{{Cite pmid|33761886}}</ref> An unexpected case of recurrence of pulmonary embolism in a patient recovered from COVID19 in full regimen dose of direct oral anticoagulant drug #MMPMID33761886 D'Elia E; Gori M; Grosu A; Iorio A; Lorini FL; Falanga A; Di Marco F; Senni M BMC Pulm Med 2021[Mar]; 21 (1): 102 PMID33761886show ga BACKGROUND: Coronavirus Disease 2019 (COVID-19) is a pandemic affecting all countries in the world. Italy has been particularly afflicted by the health emergency, and since the peak phase has passed, major concern regarding medium to long term complications due to COVID-19 is arising. Little is known in literature regarding thromboembolic complications once healed after COVID-19. CASE PRESENTATION: A 51-year-old patient recovered from COVID-19 pneumonia complicated by pulmonary embolism (PE) came to the hospital for palpitations and chest pain. Although he was on treatment dose of direct oral anticoagulation (DOAC), massive recurrent PE was diagnosed. CONCLUSION: In the early post COVID-19 era, the question remains regarding the efficacy of DOACs in COVID-19 patients. |Administration, Oral[MESH] |Anticoagulants/*administration & dosage/therapeutic use[MESH] |COVID-19/*complications[MESH] |Dabigatran/*administration & dosage/therapeutic use[MESH] |Drug Therapy, Combination[MESH] |Heparin/*administration & dosage/therapeutic use[MESH] |Humans[MESH] |Male[MESH] |Middle Aged[MESH] |Pulmonary Embolism/drug therapy/*prevention & control/*virology[MESH] |Recurrence[MESH]An unexpected case of recurrence of pulmonary embolism in a patient re(epmc).pdf DeepDyve Pubget Overpricing